Health System, Drugmakers Battle Over Dismissal Request in 340B Penny Pricing Fraud Suit

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.
A California health system and four drugmakers have filed dueling arguments over the pharmaceutical companies’ effort to dismiss a fraud [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Citing U.S. Supreme Court Decision, Health System Sues Medicare Advantage Plan for Past 340B Payments

An Alabama health system is suing Humana over past reduced 340B rates paid by its Medicare Advantage plans.
Baptist Health of Alabama sued Humana in federal court over the lack of repayment by the company’s Medicare Advantage (MA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Rules for Diabetes Drugmakers in 340B Antitrust Case, Health Center Plans Appeal

Mosaic Health plans to appeal a federal district judge's ruling against the health center's 340B antitrust case against four diabetes drugmakers.
A federal district judge last week denied two community health centers’ antitrust claims against four major diabetes drug manufacturers over [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Hospital Reaches $2.1 Million Settlement Over Alleged 340B Overbilling

After self-reporting an internal audit, Calif.-based Pomona Valley Medical Center reached a $2.1 million settlement to resolve allegations of 340B overbilling.
A California hospital last week reached a settlement to pay the state of California and the U.S. government a combined [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Ruling Creates Legal, Regulatory Uncertainty for 340B, Says Attorney Panel

Maureen Testoni, president and CEO of 340B Health, Jason Reddish, a principal at Powers Law, and Ross Margulies, a partner at Foley Hoag, discussed the looming uncertainty in 340B following a key federal district court ruling during the 340B Coalition Winter Conference.
A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genesis Decision Expected to Increase 340B Scripts, Provider-Owned Pharmacies, Says Contractor to Drug Manufacturers and Former Apexus Staffer

Gavin Magaha, senior director of innovation at Kalderos and a former Apexus executive, said a recent judicial ruling on the 340B patient definition could increase the number of 340B patients and provider-owned pharmacies.
The ruling in a recent, high-profile 340B patient definition case will likely result in providers increasing the number of patients [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Systems, HRSA Spar in Federal Court Over 340B Registration Policy Reversal

U.S. District Court of the District of Columbia
More than 40 health systems sued federal regulators over a hospital registration policy change in the U.S. District Court of the District of Columbia.
Forty-four health systems have asked a federal district court to decide, without a full trial, on their lawsuit against federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Genesis CEO Praises Court Decision, Blasts HRSA, NACHC, State Primary Care Association

Tony Megna, CEO and general counsel of Genesis Healthcare, shared his first public comments with 340B Report on a key 340B court decision.
In his first public comments since a key federal court decision on the 340B patient definition, the leader of a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amid Possible Coming Enforcement, PhRMA Again Asks Court to Block Louisiana’s 340B Contract Pharmacy Law

A drug industry trade group asked a federal district court to decide on its case against Louisiana Attorney General Liz Murrill (R) and the state's 340B contract pharmacy law without going through a trial.
After Louisiana signaled plans to possibly enforce its state 340B contract pharmacy law, a powerful drug industry trade group has [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report